Colombia vs Japan: Reported rate of new cervical cancer cases
Colombia
13.01 per 100,000 women
in 2017
Japan
11.85 per 100,000 women
in 2015
Colombia rank
8th
Japan rank
10th
Reported rate of new cervical cancer cases over time
- Colombia
- Japan
How they compare
Colombia currently reports 13.01 per 100,000 women against 11.85 per 100,000 women in Japan, a difference of 1.16 per 100,000 women.
That makes Colombia's figure about 1.1 times Japan's.
Across all 13 years both countries report, Colombia has been ahead every year.
Colombia ranks 8th and Japan ranks 10th of 46 countries.
Colombia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.18 per 100,000 women | 8.15 per 100,000 women | 11.03 per 100,000 women | Colombia |
| 2010s | 14.31 per 100,000 women | 11.03 per 100,000 women | 3.28 per 100,000 women | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Colombia or Japan?
- Colombia, at 13.01 per 100,000 women against 11.85 per 100,000 women in Japan as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Colombia and Japan?
- 1.16 per 100,000 women, with Colombia ahead.
- How many years of comparable data are there for Colombia and Japan?
- 13 years are reported by both, from 2003 to 2015.
- How do Colombia and Japan rank globally for reported rate of new cervical cancer cases?
- Colombia ranks 8th and Japan ranks 10th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.